UNSPSC 42181727: Implantable long term continuous electrocardiography EKG system

In this classification, this commodity indicates an implantable product that can record and measure electronic waves generated from the heart of a human for protracted periods of time. US FDA regulates continuous electrocardiography EKG or holter monitoring systems under 21 CFR 870.28 and under FDA product code MXC. Most nations, for tariff and trade purposes, schedule these products under HS 852849.

UNSPSC 42181727 Implantable long term continuous electrocardiography EKG system is a Commodity code describing implantable cardiac monitoring devices for continuous heart rhythm surveillance. State and local procurement under this code centers on medical supplies frameworks and cooperative purchasing vehicles that bundle multiple product categories, including implantable cardiac devices, for distribution to state agencies and participating public entities. The solicitations show activity through state health departments and cooperative purchasing consortia (NASPO ValuePoint, Sourcewell) rather than direct procurement by individual jurisdictions. Issuing bodies include state agency networks coordinating medical supply distribution and multi-state cooperative purchasing units that serve hundreds of participating entities across government, education, and the nonprofit sector.

Recent opportunities show minimal direct targeting of implantable EKG systems as standalone procurements. The NASPO ValuePoint RFP NVP_1443 (Idaho Medical Supplies), posted October 6, 2026 with proposals due November 9, 2026, establishes a medical supplies framework covering multiple product categories and is sponsored by Idaho state agencies; vendors submit comprehensive catalogs and tiered pricing for items ordered under the resulting contract. A second opportunity, Sourcewell RFP #061626 Law Enforcement Equipment, posted May 12, 2026 with responses due June 16, 2026, falls outside the code's scope and suggests potential mistagging in state and local systems. Activity under the implantable EKG code appears limited in recent state and local procurement; the category is typically embedded within broader medical supplies frameworks rather than solicited as a distinct commodity. Vendors pursuing this code should focus on cooperative purchasing vehicles serving state health departments and multi-entity consortia rather than on individual municipal or county buys.